{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:29:06Z","timestamp":1773149346381,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This research was funded by the Italian Ministry of Defense"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84952-6","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T14:09:12Z","timestamp":1737986952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era"],"prefix":"10.1038","volume":"15","author":[{"given":"Marzia","family":"Cavalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Campoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Anselmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Di Spirito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anella","family":"Monte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Lipari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfredo","family":"Bortone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Vera","family":"Fain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"D\u2019Amelio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florigio","family":"Lista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Fillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"84952_CR1","unstructured":"European Centre for Disease Prevention and Control. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/reinfection-SARS-CoV-2-implementation-surveillance-case-definition-within-eueea (2021)."},{"key":"84952_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov, P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21, 361\u2013379. https:\/\/doi.org\/10.1038\/s41579-023-00878-2 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"84952_CR3","unstructured":"World Health Organization. https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants (2024)."},{"key":"84952_CR4","unstructured":"World Health Organization. http:\/\/www.who.int\/news\/item\/16-03-2023-statement-on-the-update-of-who-s-working-definitions-and-tracking-system-for-sars-cov-2-variants-of-concern-and-variants-of-interest (2023)."},{"key":"84952_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jinf.2022.04.034","volume":"85","author":"NN Nguyen","year":"2022","unstructured":"Nguyen, N. N. et al. High rate of reinfection with the SARS-CoV-2 Omicron variant. J. Infect. 85, 174\u2013211. https:\/\/doi.org\/10.1016\/j.jinf.2022.04.034 (2022).","journal-title":"J. Infect."},{"key":"84952_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41295","author":"P Gupta","year":"2023","unstructured":"Gupta, P., Gupta, V., Singh, C. M. & Singhal, L. Emergence of COVID-19 variants: An update. Cureus https:\/\/doi.org\/10.7759\/cureus.41295 (2023).","journal-title":"Cureus"},{"key":"84952_CR7","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/jmv.27643","volume":"94","author":"D Tian","year":"2022","unstructured":"Tian, D., Sun, Y., Xu, H. & Ye, Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol. 94, 2376\u20132383. https:\/\/doi.org\/10.1002\/jmv.27643 (2022).","journal-title":"J. Med. Virol."},{"key":"84952_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2614","author":"E Simon-Loriere","year":"2011","unstructured":"Simon-Loriere, E. & Holmes, E. C. Why do RNA viruses recombine?. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/nrmicro2614 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"84952_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.898463","volume":"10","author":"D Setiabudi","year":"2022","unstructured":"Setiabudi, D., Sribudiani, Y., Hermawan, K., Andriyoko, B. & Nataprawira, H. M. The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children. Front. Pediatr. 10, 898463. https:\/\/doi.org\/10.3389\/fped.2022.898463 (2022).","journal-title":"Front. Pediatr."},{"key":"84952_CR10","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1002\/jmv.27749","volume":"94","author":"VR Rajpal","year":"2022","unstructured":"Rajpal, V. R. et al. \u201cIs Omicron mild\"? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies. J. Med. Virol. 94, 3521\u20133539. https:\/\/doi.org\/10.1002\/jmv.27749 (2022).","journal-title":"J. Med. Virol."},{"key":"84952_CR11","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1093\/cid\/ciab079","volume":"73","author":"SM Moghadas","year":"2021","unstructured":"Moghadas, S. M. et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin. Infect. Dis. 73, 2257\u20132264. https:\/\/doi.org\/10.1093\/cid\/ciab079 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"84952_CR12","unstructured":"European Centre for Disease Prevention and Control. https:\/\/www.ema.europa.eu\/en\/documents\/other\/ecdc-ema-statement-updating-covid-19-vaccines-composition-new-sars-cov-2-virus-variants_en.pdf (2023)."},{"key":"84952_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12929-022-00853-8","volume":"29","author":"WY Chi","year":"2022","unstructured":"Chi, W. Y. et al. COVID-19 vaccine update: Vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J. Biomed. Sci. 29, 82. https:\/\/doi.org\/10.1186\/s12929-022-00853-8 (2022).","journal-title":"J. Biomed. Sci."},{"key":"84952_CR14","unstructured":"European Medicine Agency. https:\/\/www.ema.europa.eu\/en\/news\/ecdc-ema-update-recommendations-additional-booster-doses-mrna-covid-19-vaccines (2022)."},{"key":"84952_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.898192","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z., Zhu, Y. & Chu, M. Role of COVID-19 Vaccines in SARS-CoV-2 variants. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.898192 (2022).","journal-title":"Front. Immunol."},{"key":"84952_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cid\/ciaa1330","volume":"73","author":"J Van Elslande","year":"2021","unstructured":"Van Elslande, J. et al. Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain. Clin. Infect. Dis. 73, 354\u2013356. https:\/\/doi.org\/10.1093\/cid\/ciaa1330 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"84952_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2022.101021","author":"CJ Toro-Huamanchumo","year":"2022","unstructured":"Toro-Huamanchumo, C. J. et al. Clinical and epidemiological features of patients with COVID-19 reinfection: A systematic review. New Microbes New Infect. https:\/\/doi.org\/10.1016\/j.nmni.2022.101021 (2022).","journal-title":"New Microbes New Infect."},{"key":"84952_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/vaccines11071185","volume":"2023","author":"MROC Chisale","year":"2019","unstructured":"Chisale, M. R. O. C. et al. (COVID-19) reinfection rates in Malawi: A possible tool to guide vaccine prioritisation and immunisation policies. Vaccines 2023, 11. https:\/\/doi.org\/10.3390\/vaccines11071185 (2019).","journal-title":"Vaccines"},{"key":"84952_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41256-022-00245-3","volume":"7","author":"X Ren","year":"2022","unstructured":"Ren, X. et al. Reinfection in patients with COVID-19: A systematic review. Glob. Health Res. Policy 7, 12. https:\/\/doi.org\/10.1186\/s41256-022-00245-3 (2022).","journal-title":"Glob. Health Res. Policy"},{"key":"84952_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41392-022-01105-9","volume":"7","author":"S Xia","year":"2022","unstructured":"Xia, S., Wang, L., Zhu, Y., Lu, L. & Jiang, S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal Transduct. Target Ther. 7, 241. https:\/\/doi.org\/10.1038\/s41392-022-01105-9 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"84952_CR21","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Grande, C. et al. Microbiology-ID COVID 19 Study Group. Early SARS-CoV-2 reinfections involving the same or different genomic lineages, Spain. Emerg. Infect. Dis. 29, 1154\u20131161 (2023). https:\/\/doi.org\/10.3201\/eid2906.221696.","DOI":"10.3201\/eid2906.221696"},{"key":"84952_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","volume":"7","author":"BJ Willett","year":"2022","unstructured":"Willett, B. J. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. 7, 1161\u20131179. https:\/\/doi.org\/10.1038\/s41564-022-01143-7 (2022).","journal-title":"Nat. Microbiol."},{"key":"84952_CR23","doi-asserted-by":"publisher","first-page":"13845","DOI":"10.1111\/eci.13845","volume":"52","author":"ME Flacco","year":"2022","unstructured":"Flacco, M. E. et al. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis. Eur. J. Clin. Investig. 52, 13845. https:\/\/doi.org\/10.1111\/eci.13845 (2022).","journal-title":"Eur. J. Clin. Investig."},{"key":"84952_CR24","doi-asserted-by":"publisher","unstructured":"Burkholz, S.; Rubsamen, M.; Blankenber, L.; Carback, R.T.; Mochly-Rosen, D.; Harris, P.E. Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron Commun Biol 6, 288 (2023). https:\/\/doi.org\/10.1038\/s42003-023-04687-4.","DOI":"10.1038\/s42003-023-04687-4"},{"key":"84952_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn4947","author":"JRC Pulliam","year":"2022","unstructured":"Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science https:\/\/doi.org\/10.1126\/science.abn4947 (2022).","journal-title":"Science"},{"key":"84952_CR26","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3201\/eid2808.220617","volume":"28","author":"L Nevejan","year":"2022","unstructured":"Nevejan, L. et al. Early SARS-CoV-2 reinfections within 60 days and implications for retesting policies. Emerg. Infect. Dis. 28, 1729\u20131731. https:\/\/doi.org\/10.3201\/eid2808.220617 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"84952_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jinf.2022.07.003","volume":"85","author":"I Vera-Lise","year":"2022","unstructured":"Vera-Lise, I. et al. Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants. J. Infect. 85, 96\u201398. https:\/\/doi.org\/10.1016\/j.jinf.2022.07.003 (2022).","journal-title":"J. Infect."},{"key":"84952_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/vaccines10101757","volume":"10","author":"H Jacobsen","year":"2022","unstructured":"Jacobsen, H. et al. Post-vaccination neutralization responses to omicron sub-variants. Vaccines (Basel) 10, 1757. https:\/\/doi.org\/10.3390\/vaccines10101757 (2022).","journal-title":"Vaccines (Basel)"},{"key":"84952_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/vaccines11020224","volume":"11","author":"H Mohammed","year":"2023","unstructured":"Mohammed, H. et al. A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by the omicron variant (B.1.1.529). Vaccines (Basel) 11, 224. https:\/\/doi.org\/10.3390\/vaccines11020224 (2023).","journal-title":"Vaccines (Basel)"},{"key":"84952_CR30","unstructured":"NEXTCLADE. https:\/\/clades.nextstrain.org\/ (2023)."},{"key":"84952_CR31","unstructured":"GISAID. https:\/\/gisaid.org\/ (2023)."},{"key":"84952_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.898192","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z., Zhu, Y. & Chu, M. Role of COVID-19 vaccines in SARS-CoV-2 variants. Front. Immunol. 13, 898192. https:\/\/doi.org\/10.3389\/fimmu.2022.898192 (2022).","journal-title":"Front. Immunol."},{"key":"84952_CR33","doi-asserted-by":"publisher","unstructured":"Cai, J. et al. Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023. Emerg. Microbes Infect. (2024). https:\/\/doi.org\/10.1080\/22221751.2023.2292071.","DOI":"10.1080\/22221751.2023.2292071"},{"key":"84952_CR34","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41598-022-05325-5","volume":"12","author":"S Rahman","year":"2022","unstructured":"Rahman, S. et al. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci. Rep. 12, 1438. https:\/\/doi.org\/10.1038\/s41598-022-05325-5 (2022).","journal-title":"Sci. Rep."},{"key":"84952_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100011","author":"L Ya\u2019qoub","year":"2021","unstructured":"Ya\u2019qoub, L., Elgendy, I. Y. & Pepine, C. J. Sex and gender differences in COVID-19: More to be learned. Am. Heart J. Plus https:\/\/doi.org\/10.1016\/j.ahjo.2021.100011 (2021).","journal-title":"Am. Heart J. Plus"},{"key":"84952_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.07.030","author":"J Slezak","year":"2021","unstructured":"Slezak, J. et al. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2021.07.030 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"84952_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.01.012","author":"AA Mensah","year":"2022","unstructured":"Mensah, A. A. et al. Disease severity during SARS-COV-2 reinfection: A nationwide study. J. Infect. https:\/\/doi.org\/10.1016\/j.jinf.2022.01.012 (2022).","journal-title":"J. Infect."},{"key":"84952_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24220-7","author":"L Deng","year":"2022","unstructured":"Deng, L. et al. Risk of SARS-CoV-2 reinfection: A systematic review and meta-analysis. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-022-24220-7 (2022).","journal-title":"Sci. Rep."},{"key":"84952_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/d41586-022-00471-2","volume":"602","author":"E Callaway","year":"2022","unstructured":"Callaway, E. Why does the Omicron sub-variant spread faster than the original?. Nature 602, 556\u2013557. https:\/\/doi.org\/10.1038\/d41586-022-00471-2 (2022).","journal-title":"Nature"},{"key":"84952_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681. https:\/\/doi.org\/10.1038\/s41586-021-04388-0 (2022).","journal-title":"Nature"},{"key":"84952_CR41","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602. https:\/\/doi.org\/10.1038\/s41586-022-04980-y (2022).","journal-title":"Nature"},{"key":"84952_CR42","doi-asserted-by":"publisher","first-page":"01190-4","DOI":"10.1016\/j.cell.2022.09.018","volume":"8674","author":"I Kimura","year":"2022","unstructured":"Kimura, I. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell 8674, 01190\u20134. https:\/\/doi.org\/10.1016\/j.cell.2022.09.018 (2022).","journal-title":"Cell"},{"key":"84952_CR43","doi-asserted-by":"publisher","first-page":"104158","DOI":"10.1016\/j.ebiom.2022.104158","volume":"82","author":"A Wilhelm","year":"2022","unstructured":"Wilhelm, A. et al. Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies. EBioMedicine 82, 104158. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104158 (2022).","journal-title":"EBioMedicine"},{"key":"84952_CR44","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1038\/s41467-022-33498-0","volume":"13","author":"FP Lyngse","year":"2022","unstructured":"Lyngse, F. P. et al. Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark. Nat. Commun. 13, 5760. https:\/\/doi.org\/10.1038\/s41467-022-33498-0 (2022).","journal-title":"Nat. Commun."},{"key":"84952_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05053-w","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature https:\/\/doi.org\/10.1038\/s41586-022-05053-w (2022).","journal-title":"Nature"},{"key":"84952_CR46","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1002\/hsr2.1873","volume":"7","author":"G Erabi","year":"2024","unstructured":"Erabi, G. et al. SARS-CoV-2 Omicron (BA.4, BA.5) variant: Lessons learned from a new variant during the COVID-19 pandemic. Health Sci Rep. 7, e1873. https:\/\/doi.org\/10.1002\/hsr2.1873 (2024).","journal-title":"Health Sci Rep."},{"key":"84952_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01892-2","author":"S Harari","year":"2022","unstructured":"Harari, S. Evolutionary insight into the emergence of SARS-CoV-2 variants of concern. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-022-01892-2 (2022).","journal-title":"Nat. Med."},{"key":"84952_CR48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(22)00015-9","volume":"22","author":"T Burki","year":"2022","unstructured":"Burki, T. The origin of SARS-CoV-2 variants of concern. Lancet Infect. Dis. 22, 174\u2013175. https:\/\/doi.org\/10.1016\/S1473-3099(22)00015-9 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"84952_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMsb2104756","volume":"385","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. SARS-CoV-2 variants in patients with immunosuppression. N. Engl. J. Med. 385, 562\u2013566. https:\/\/doi.org\/10.1056\/NEJMsb2104756 (2021).","journal-title":"N. Engl. J. Med."},{"key":"84952_CR50","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s15010-021-01651-4","volume":"49","author":"HR Choudhary","year":"2021","unstructured":"Choudhary, H. R. et al. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection. Infection 49, 1045\u20131048. https:\/\/doi.org\/10.1007\/s15010-021-01651-4 (2021).","journal-title":"Infection"},{"key":"84952_CR51","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","volume":"383","author":"B Choi","year":"2020","unstructured":"Choi, B. et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 383, 2291\u20132293. https:\/\/doi.org\/10.1056\/NEJMc2031364 (2020).","journal-title":"N. Engl. J. Med."},{"key":"84952_CR52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","volume":"592","author":"SA Kemp","year":"2021","unstructured":"Kemp, S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature 592, 277\u2013282. https:\/\/doi.org\/10.1038\/s41586-021-03291-y (2021).","journal-title":"Nature"},{"key":"84952_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27331","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.27331 (2022).","journal-title":"J. Med. Virol."},{"key":"84952_CR54","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1038\/s41467-022-30649-1","volume":"13","author":"J Tang","year":"2022","unstructured":"Tang, J. et al. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat. Commun. 13, 4732. https:\/\/doi.org\/10.1038\/s41467-022-30649-1 (2022).","journal-title":"Nat. Commun."},{"key":"84952_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/22221751.2022.2035195","volume":"11","author":"LL Chen","year":"2022","unstructured":"Chen, L. L. et al. Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine. Emerg. Microbes Infect. 11, 543\u2013547. https:\/\/doi.org\/10.1080\/22221751.2022.2035195 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"84952_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41590-021-01089-8","volume":"23","author":"AC Dowell","year":"2022","unstructured":"Dowell, A. C. et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat. Immunol. 23, 40\u201349. https:\/\/doi.org\/10.1038\/s41590-021-01089-8 (2022).","journal-title":"Nat. Immunol."},{"key":"84952_CR57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics 26, 589\u2013595. https:\/\/doi.org\/10.1093\/bioinformatics\/btp698 (2010).","journal-title":"Bioinformatics"},{"key":"84952_CR58","unstructured":"Garrison, E. P. & Marth, G. T. Haplotype-based variant detection from short-read sequencing. Genomics (2012). arXiv:1207.3907."},{"key":"84952_CR59","unstructured":"ARTIC network. https:\/\/artic.network\/ncov-2019\/ncov2019-bioinformatics-sop.html (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84952-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T14:09:20Z","timestamp":1737986960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84952-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84952"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84952-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3372"}}